Anti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric Castleman's disease
about
Update and new approaches in the treatment of Castleman diseaseKSHV infects a subset of human tonsillar B cells, driving proliferation and plasmablast differentiation.Kaposi sarcoma herpes virus-associated hemophagocytic syndrome complicated by multicentric castleman disease and kaposi sarcoma in a HIV-negative immunocompetent patient: an autopsy case.Successful treatment of a Caucasian case of multifocal Castleman's disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report.Increase of hemoglobin levels by anti-IL-6 receptor antibody (tocilizumab) in rheumatoid arthritis.Castleman's disease imitating adrenal mass in the retroperitoneal area.An immunotoxin targeting the gH glycoprotein of KSHV for selective killing of cells in the lytic phase of infectionIL-6 promotes acute and chronic inflammatory disease in the absence of SOCS3.Patient-reported Outcomes for Multicentric Castleman's Disease in a Randomized, Placebo-controlled Study of Siltuximab.Selective killing of Kaposi's sarcoma-associated herpesvirus lytically infected cells with a recombinant immunotoxin targeting the viral gpK8.1A envelope glycoprotein.Tocilizumab for steroid refractory acute graft-versus-host diseaseTocilizumab for the treatment of steroid refractory graft-versus-host disease.The role of inflammation and autoimmunity in the pathophysiology of pulmonary arterial hypertension.The role of tocilizumab in the management of rheumatoid arthritis.Targeting interleukin-6 in rheumatoid arthritis.Multicentric Castleman's disease: a challenging diagnosis.Inflammation and the Silent Sequelae of Stroke.Modulation of Kaposi's sarcoma-associated herpesvirus interleukin-6 function by hypoxia-upregulated protein 1.HHV8/KSHV-Positive Lymphoproliferative Disorders and the Spectrum of Plasmablastic and Plasma Cell Neoplasms: 2015 SH/EAHP Workshop Report-Part 3.Clinical and laboratory characterization of a large cohort of patients with Castleman disease retrospectively collected from a single center.Is tocilizumab a potential therapeutic option for refractory unicentric Castleman disease?Evaluation of changes in magnetic resonance images following 24 and 52 weeks of treatment of rheumatoid arthritis with infliximab, tocilizumab, or abatacept.
P2860
Q26740703-6A7BF6B9-CC22-477E-86BD-F8B880D9E4E2Q30433391-926891A6-0E2E-40E8-97AE-D8FCD8BC5196Q33386458-D0F18ACD-F957-4A7B-8177-237AA8C1F5DAQ33420286-B9A9A0DE-41C3-43F4-A1AE-CEBDB1C72695Q33689977-A65598C8-A2D6-4EDC-9209-4697388D21E1Q34995598-E634F33F-9F2F-448C-AF2C-92C462ED8A6FQ35007502-2141A9D0-C1A0-404C-85C6-6613198E6A0EQ35137626-0B4CAFBA-9A7A-4532-BB29-BBC9BAA73BA5Q35252771-5632C8AA-4B72-4D99-AE79-556AB9EDEDDBQ35992503-D715C0E8-38D9-404F-BFD6-CB17E6302689Q36422339-8F07F8DE-864E-4BDF-AC5A-A4434CA4CE4BQ37026278-34A7B545-6B3A-44B8-B7A0-D5ACD6F8D5A4Q37851851-501BB84B-5649-41F4-8809-775EEEECAEB6Q38030974-911B53FB-D6E7-4215-B5DB-41F67DA2DCC6Q38086137-5C4D41BD-9163-4451-B694-3401DBAB277EQ38091671-D82DC779-19EA-45DA-AD49-E7F5D1CE738EQ38871034-D49A6130-EF74-4655-BA25-4C64E4EA5E5CQ38985652-BAFCD068-F305-4374-A75C-B1F7427A29F5Q39232108-3E5D3483-820B-42CA-BD48-D688D9905D89Q46670592-914EA3A3-61A8-4669-8EEC-BD86AC04C094Q48287167-95A79685-8A40-4DB7-9034-BB324B8D9C3BQ53441582-52AB44F5-4C39-4395-B427-A1F9C388511A
P2860
Anti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric Castleman's disease
description
2007 nî lūn-bûn
@nan
2007 թուականին հրատարակուած գիտական յօդուած
@hyw
2007 թվականին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Anti-interleukin-6 receptor an ...... lticentric Castleman's disease
@ast
Anti-interleukin-6 receptor an ...... lticentric Castleman's disease
@en
Anti-interleukin-6 receptor an ...... lticentric Castleman's disease
@nl
type
label
Anti-interleukin-6 receptor an ...... lticentric Castleman's disease
@ast
Anti-interleukin-6 receptor an ...... lticentric Castleman's disease
@en
Anti-interleukin-6 receptor an ...... lticentric Castleman's disease
@nl
prefLabel
Anti-interleukin-6 receptor an ...... lticentric Castleman's disease
@ast
Anti-interleukin-6 receptor an ...... lticentric Castleman's disease
@en
Anti-interleukin-6 receptor an ...... lticentric Castleman's disease
@nl
P2093
P3181
P1433
P1476
Anti-interleukin-6 receptor an ...... lticentric Castleman's disease
@en
P2093
Akito Tsutsumi
Daisuke Goto
Hiroto Tsuboi
Isao Matsumoto
Masashi Matsuyama
Satoshi Ito
Takayuki Sumida
Takeshi Suzuki
P3181
P356
10.2169/INTERNALMEDICINE.46.6262
P407
P577
2007-01-01T00:00:00Z